1. Home
  2. VRCA

as 06-20-2025 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Founded: 2013 Country:
United States
United States
Employees: N/A City: WEST CHESTER
Market Cap: 54.0M IPO Year: 2018
Target Price: $6.00 AVG Volume (30 days): 245.7K
Analyst Decision: Hold Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.03 EPS Growth: N/A
52 Week Low/High: $0.38 - $8.98 Next Earning Date: 08-13-2025
Revenue: $7,179,000 Revenue Growth: -19.45%
Revenue Growth (this year): 171.87% Revenue Growth (next year): 71.38%

VRCA Daily Stock ML Predictions

Share on Social Networks: